383 (897) 441 ( (1121) 1506 (1036) 1579 (1179) 1714 (1243) Lp-PLA2 ## activity, μmol/min/L 171 (47) 175 (49) 179 (49) 179 (48) Figure S1 . Kaplan-Meier curves for major adverse cardiovascular event (MACE) by baseline white blood cell (WBC) quartile groups (Q) Figure S2 . Spline plots for major adverse cardiovascular event (MACE), cardiovascular (CV) death, myocardial infarction (MI), heart failure and stroke by baseline quartile groups of white blood cell count (WBC). Adjustment model: Adjustments for randomized treatment, age, systolic BP, BMI, sex, history of hypertension, geographic region for final reporting, prior MI, prior coronary revascularization (PCI or CABG), prior multivessel CHD, baseline diabetes, smoking, polyvascular disease, significant renal dysfunction, HB, WBC, LDL-C, HDL-C, triglycerides, eGFR (according to CKD-EPI), hsTroponin T, NT-proBNP, IL-6, Cystatin C, Lp-PLA2 and GDF-15
